Tech Company Financing Transactions

AN2 Therapeutics Funding Round

Mountain Group Capital, Adjuvant Capital and BioRock Ventures invested in a $12 million Series A funding round for AN2 Therapeutics. The financing round closed on 11/26/2019.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series A
Proceeds Purpose
Proceeds from the financing will be used to advance AN2's lead clinical-stage program, involving a therapeutic agent with a novel mechanism-of-action, as well as several earlier stage programs.

Company Information

Company Status
Private & Independent
Mailing Address
171 Forest Ln.
Menlo Park, CA 94025
Email Address
Not Recorded
AN2 Therapeutics, Inc. is a California-based global health biopharmaceutical company focused on bringing the power of modern biomedical and drug development expertise to provide transformational medicines for patients suffering from infectious diseases.
AN2 Therapeutics LinkedIn Company Profile
Social Media
AN2 Therapeutics Company Twitter Account
Company News
AN2 Therapeutics News
AN2 Therapeutics on Facebook
AN2 Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Eric Easom
  Eric Easom LinkedIn Profile  Eric Easom Twitter Account  Eric Easom News  Eric Easom on Facebook
Chief Financial Officer
Lucy Day
  Lucy Day LinkedIn Profile  Lucy Day Twitter Account  Lucy Day News  Lucy Day on Facebook
Chief Financial Officer
Paul Eckburg
  Paul Eckburg LinkedIn Profile  Paul Eckburg Twitter Account  Paul Eckburg News  Paul Eckburg on Facebook
Michael Alley
  Michael Alley LinkedIn Profile  Michael Alley Twitter Account  Michael Alley News  Michael Alley on Facebook
Vice President
Vince Hernandez
  Vince Hernandez LinkedIn Profile  Vince Hernandez Twitter Account  Vince Hernandez News  Vince Hernandez on Facebook
VP - Bus. Development
Sanjay Chanda
  Sanjay Chanda LinkedIn Profile  Sanjay Chanda Twitter Account  Sanjay Chanda News  Sanjay Chanda on Facebook
VP - Manufacturing
Kieron Wesson
  Kieron Wesson LinkedIn Profile  Kieron Wesson Twitter Account  Kieron Wesson News  Kieron Wesson on Facebook
VP - Operations
Kevin Krause
  Kevin Krause LinkedIn Profile  Kevin Krause Twitter Account  Kevin Krause News  Kevin Krause on Facebook



Browse more venture capital transactions:

Prev: 11/26/2019: Capitolis venture capital transaction
Next: 11/26/2019: Copper Labs venture capital transaction


Share this article


About Our Venture Capital Transactions Database

We do our best to record all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary